(Q39874741)

15 September 2017

1 reference

title

Biochemistry of affective disorders. (A review of the literature). (English)

1 reference

15 September 2017

Aillon GA

1

1 reference

15 September 2017

1 July 1971

1 reference

15 September 2017

1 reference

15 September 2017

12

1 reference

15 September 2017

4

1 reference

15 September 2017

260-272

1 reference

On the chemical basis of mood

15 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

A dualistic approach to some biochemical problems in endogenous depressions

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

The biochemistry of affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Neuropsychopharmacology and the affective disorders (second of three parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Neurochemical correlates of behaviour. Changes in acetylcholine, norepinephrine and 5-hydroxytryptamine concentrations in several discrete brain areas of the rat during behavioural excitation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Catecholamine metabolism in affective disorders. II. Norepinephrine, normetanephrine, epinephrine, metanephrine, and VMA excretion in hypomanic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

The catecholamine hypothesis of depressions: Further arguments

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Uptake of 5-hydroxytryptamine and 5-hydroxytryptophan by neurons of the central nervous system normally containing catecholamines

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

5-Hydroxytryptamine in the Hind-Brain of Depressive Suicides

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Tryptamine metabolism in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Potentiation of the antidepressive effect of a monoamine-oxidase inhibitor by tryptophan

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Depression with the Use of Alpha-Methyldopa

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Neuropsychopharmacology and the affective disorders. (Third of three parts)

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Lithium-carbonate treatment in depression and mania. A longitudinal double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

The role of electrolytes in affective disorders. Sodium, potassium, and lithium ions

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Lithium ion retention and distribution. Patterns during acute mania and normothymia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Biochemical Aspects of Lithium in Affective Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Neuropsychopharmacology and the affective disorders. (First of three parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

METABOLISM OF (H3)NOREPINEPHRINE IN THE RAT BRAIN

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

The penetration of 5-hydroxytryptamine through the blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Relationship of hallucinogens to adrenergic cerebral neurohumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Tryptophan Pyrrolase—A Biochemical Factor in Depressive Illness?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Metabolic changes in depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Electrolytes and depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Body Water Variations in Manic-Depressive Psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Variations in Body Water during Recovery from Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Mineral metabolism, mania, and melancholia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Potassium and Water Distribution in Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Mineral Metabolism in Affective Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Abnormality of the blood-cerebrospinal fluid barrier of patients suffering from a depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

EFFECTS OF LITHIUM CARBONATE ON ELECTROLYTE DISTRIBUTION IN MAN

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Sodium Balance and Distribution in Lithium Carbonate Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Plasma Magnesium and Calcium in Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

The variability of plasma 17-hydroxycorticosteroids—levels in affective illness and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Pituitary adrenal function and depression. An outline for research

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Plasma cortisol in depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Variations in II-Hydroxycorticosteroids in Depression and Manic-Depressive Psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Studies on the active transport of lithium in the isolated frog skin

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Corticosteroids in depressive illness. II. A longitudinal psychoendocrine study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Pituitary-adrenal function in severe depressive illness.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

CORTISOL SECRETION RATE IN DEPRESSIVE ILLNESS

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Psychological stress and endocrine functions; blood levels of adrenocortical and thyroid hormones in acutely disturbed patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

POSSIBILITY OF A BIOCHEMICAL TEST FOR SUICIDAL POTENTIAL: AN ANALYSIS OF ENDOCRINE FINDINGS PRIOR TO THREE SUICIDES.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Circadian rhythm of adrenal cortical activity in depression. I. A comparison of depressed patients with normal subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Mood, motility and 17-hydroxycorticoid excretion; a polyvariable case study.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

STUDY OF A PATIENT WITH 48-HOUR MANIC-DEPRESSIVE CYCLES. II. STRONG POSITIVE CORRELATION BETWEEN ENDOCRINE FACTORS AND MANIC DEFENSE PATTERNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Tryptophan metabolism in affective psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

The diurnal variation of plasma cortisol levels in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Circadian rhythm of adrenal cortical activity in depression. II. A comparison of types in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

The diurnal rhythm of plasma cortisol concentration in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Circadian rhythm of plasma 11-hydroxycorticosteroids in depressive illness, congestive heart failure, and Cushing's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Glucose Tolerance in Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

THE RELATIONSHIP BETWEEN 17-HYDROXYCORTICOSTEROID EXCRETION AND GLUCOSE UTILIZATION IN DEPRESSIONS.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Intravenous Glucose Tolerance Test in Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Laboratory findings in affective and schizophrenic psychoses.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Differences in the metabolism of norepinephrine in depressions. The effects of various therapies.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

The metabolism of norepinephrine in depressions. Differences and effects of therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

BIOLOGICAL ASPECTS OF ELECTROCONCLUSIVE THERAPY.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Interrelationships between electroshock, the blood-brain barrier, and catecholamines

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

The relationship between antigammaglobulin activity and depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Water distribution in affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Enhancement of imipramine antidepressant activity by thyroid hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Serum-pseudocholinesterase in depression with notable anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

Psychopharmacological Aspects of Mental Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2871%2971517-5

7 January 2021

10.1016/S0033-3182(71)71517-5

Identifiers

DOI

1 reference

15 September 2017

1 reference

PubMed ID

4153287